Coeliac disease [5] (multiple letters)

Lancet

Volumn 362, Issue 9393, 2003, Pages 1418-1419

  Burgin Wolff A ^a   Hadziselimovic, F ^a   Green, Peter H R ^c   Jabri, Bana ^b  

^a Institute for Coeliac Disease   (Switzerland)

^b UNIVERSITY OF CHICAGO   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENDOMYSIUM ANTIBODY; GLIADIN ANTIBODY; IMMUNOGLOBULIN A; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

CELIAC DISEASE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUTEN FREE DIET; HUMAN; INTESTINE BIOPSY; LETTER; PRIORITY JOURNAL; SEROLOGY;

EID: 0242285676     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14653-3     Document Type: Letter

References (5)

1. PHR Green B Jabri Coeliac disease Lancet 362 2003 383 391
2. A Bürgin-Wolff F Hadziselimovic Screening tests for coeliac disease Lancet 349 1997 1843 1844
3. F Hadziselimovic A Bürgin-Wolff Coeliac disease Lancet 351 1998 62 63
4. A Bürgin-Wolff I Dahlbom F Hadziselimovic CJ Petersson Antibodies against human tissue transglutaminase and endomysium in diagnosing and monitoring coeliac disease Scand J Gastroenterol 37 2002 685 691
5. F Leon C Camarero R R-Pena Antitransglutaminase IgA ELISA: clinical potential and drawbacks in coeliac disease diagnosis Scand J Gastroenterol 36 2001 849 853